热敏灸配合盆底肌功能锻炼治疗产后尿失禁的临床疗效研究

目的:探讨热敏灸配合盆底肌功能锻炼治疗产后尿失禁的临床疗效。方法:选择2019年8月—2020年8月收治的产后尿失禁产妇84例,按抽签法分为观察组和对照组,每组42例。对照组采用常规锻炼治疗,观察组在对照组的基础上实施热敏灸治疗。比较两组患者的排尿评分、盆底肌收缩力评分以及国际尿失禁咨询委员会问卷简表(ICI-Q-SF)评分。结果:治疗后,观察组的排尿评分以及ICI-Q-SF评分均低于对照组,差异有统计学意义(P<0.05);观察组的盆底肌收缩力评分较对照组有所改善,差异有统计学意义(P<0.05);观察组的不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论:对产后尿失禁患者采用热敏灸配合盆底肌功能锻炼治疗,可改善产妇排尿状况,增强盆底肌的紧张度和收缩力,缓解产后尿失禁,降低不良反应的发生率。

Study on the clinical effect of heat-sensitive moxibustion combined with pelvic floor muscle exercises on postpartum urinary incontinence

Objective:To investigate the clinical efficacy of heat-sensitive moxibustion combined with pelvic floor muscle exercises in the treatment of postpartum urinary incontinence.Methods:A total of 84 cases of postpartum urinary incontinence women admitted to our hospital from August 2019 to August 2020 were selected and divided into observation group and control group according to the lottery method,with 42 cases in each group.The control group was treated with conventional exercise,and the observation group was treated with heat-sensitive moxibustion on the basis of the control group.the urination score,pelvic floor muscle contractility score and summary questionnaire of the international consultative committee on urinary incontinence(ICI-Q-SF)score were compared between the two groups.Results:After treatment,the urination score and ICI-Q-SF score of the observation group were lower than those of the control group,the difference was statistically significant(P<0.05).The pelvic floor muscle contractility score of the observation group was better than that of the control group,with significant difference(P<0.05).The incidence of adverse reactions of the observation group was significantly lower than that of the control group,with significant difference(P<0.05).Conclusion:Heat sensitive moxibustion combined with pelvic floor muscle functional exercise can improve the urination status of puerpera,enhance the tension and contraction of pelvic floor muscle,relieve postpartum urinary incontinence and reduce the incidence of adverse reactions.